1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Market Study on Neurosurgical Products: Asia Pacific to Witness Highest Growth by 2022

Neurosurgery is a branch of medicine that deals with prevention, diagnosis, and treatment of nervous system disorders and rehabilitation of patients suffering from the disorder post-surgery. Neurosurgery is mainly performed for treating neuro-trauma and intracranial hemorrhage. Brain stroke is one of the major causes of hemorrhage.The major reason for stroke is ischemia, wherein supply of blood to the brain is suddenly interrupted. Due to lack of proper blood supply, the brain starves of oxygen and glucose, which initiates various molecular reactions in the brain leading to brain damage. The extent of brain damage depends upon the duration of interruption of blood supply. Another cause of brain hemorrhage is a neural aneurysm. According to the American Heart Association, approximately 1.5%–5% people across the globe develop a cerebral aneurysm in their lifetime. Elderly people are more susceptible to neurological disorders as compared to other adults. With surging aging population, the incidence of neurodegenerative diseases is increasing, in turn, driving demand for effective neurosurgical products for their treatment.

Among regions, North America dominates the global market for neurosurgical products due to a rapid rise in aging population, increasing healthcare expenditure, and developed healthcare infrastructure in the region. The neurosurgical products market in Asia-Pacific is expected to show high growth rates over the next five years, with China and India being the fastest-growing markets in the region. Key driving forces of the neurosurgical products market in developing countries are: large pool of patients, increasing disposable income, growing geriatric population, increasing incidence of brain tumor, rising healthcare awareness, growing healthcare expenditure, and improving healthcare infrastructure in these regions.

In addition, various government bodies are providing funds and grants for development of neurosurgical products, which is further fueling the growth of the global neurosurgical products market. On the other hand, availability of alternative treatment for neurological diseases, stringent regulatory requirements, and long approval time for new neurosurgical products are some of the factors inhibiting the growth of the global neurosurgical products market. However, growing demand for minimally invasive surgeries is projected to create significant growth opportunities for the global neurosurgical products market.

This report provides in-depth analysis and estimation of the neurosurgical products market for the period 2015–2022, considering 2014 as the base year for calculation. Moreover, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report.

The market has been segmented on the basis of the following:
By product type
Shunts
Neurosurgical endoscope
Stereotactic radio-surgery systems
Embolization products
Aneurysm and AVM clips
Others
By condition
Hydrocephalus
Aneurysms
Arteriovenous Malformations
Pituitary and intracranial tumor
Others
By procedure
Open surgery
Neurovascular and minimally invasive surgery
Key geographies evaluated in this report are:
North America
U.S.
Rest of North America
Europe
France
Germany
U.K.
Rest of Europe
APAC
China
India
Japan
Rest of Asia Pacific
Top companies profiled in this report are
Integra LifeSciences Holdings Corporation
KARL STORZ GmbH & Co. KG
Medtronic plc
Johnson & Johnson Services, Inc.
Stryker Corporation
Elekta AB
Terumo Corporation
Penumbra, Inc.
B. Braun Melsungen AG
Varian Medical Systems, Inc.
Key features of this report
Drivers, restraints, and challenges shaping the neurosurgical products market dynamics
Latest innovations and key events in the market
Analysis of business strategies of the top players in the market
Neurosurgical products market estimates and forecasts

Table Of Contents

Global Market Study on Neurosurgical Products: Asia Pacific to Witness Highest Growth by 2022
Chapter 1 Preface 9

1.1 Report Description 9

1.2 Research Methodology 10

1.3 Assumptions 10

Chapter 2 Market Synopsis 11

Chapter 3 Porter's Five Forces Analysis 12

3.1 Bargaining Power of Suppliers 12

3.2 Bargaining Power of Buyers 13

3.3 Threat of New Entrants 13

3.4 Threat of Substitutes 13

3.5 Intensity of Rivalry 14

Chapter 4 Industry Overview 15

4.1 Market Definition 15

4.2 Market Drivers 16

4.2.1 Growing geriatric population 16

4.2.2 Growing government funding 17

4.2.3 Increasing incidence of brain tumor 18

4.2.4 Rising awareness about neurological disorders 18

4.3 Impact Analysis of Market Drivers 18

4.4 Market Restraints 19

4.4.1 Availability of alternative treatment for neurological diseases 19

4.4.2 Stringent regulatory requirements and long approval times for new neurosurgical products 19

4.5 Impact Analysis of Market Restraints 20

4.6 Opportunities 20

4.6.1 Growing demand for minimally invasive surgeries 20

Chapter 5 Global Market Size and Forecast 22

Chapter 6 Market Size and Forecast by Condition 30

6.1 Hydrocephalus 30

6.2 Aneurysms 32

6.3 Arteriovenous malformations 34

6.4 Pituitary and intracranial tumors 35

Chapter 7 Market Size and Forecast by Procedure 38

7.1 Open Neurosurgery 38

7.2 Neurovascular and Minimally Invasive Surgery 39

Chapter 8 Market Size and Forecast by Product Type 42

8.1 Shunts 42

8.2 Neurosurgical Endoscope 44

8.3 Stereotactic Radio-surgery System 46

8.4 Embolization Products 48

8.5 Aneurysm and AVM Clips 50

Chapter 9 Market Size and Forecast by Geography 52

9.1 North America 52

9.2 Europe 54

9.3 Asia-Pacific 56

Chapter 10 Competitive Scenario 60

10.1 Competitive Analysis 60

Chapter 11 Company Profiles 62

11.1 Integra LifeSciences Holdings Corporation 62

11.1.1 Company overview 62

11.1.2 Products and services 62

11.1.3 Financial performance 63

11.1.4 Key developments 64

11.2 KARL STORZ GmbH and Co. KG. 65

11.2.1 Company overview 65

11.2.2 Products and services 65

11.2.3 Financial performance 66

11.2.4 Key developments 66

11.3 Medtronic plc 67

11.3.1 Company overview 67

11.3.2 Products and services 68

11.3.3 Financial performance 69

11.3.4 Key developments 69

11.4 Johnson and Johnson Services, Inc. 70

11.4.1 Company overview 70

11.4.2 Products and services 71

11.4.3 Financial performance 72

11.4.4 Key developments 72

11.5 Stryker Corporation 73

11.5.1 Company overview 73

11.5.2 Products and services 73

11.5.3 Financial performance 74

11.5.4 Key developments 74

11.6 Elekta AB 75

11.6.1 Company overview 75

11.6.2 Products and services 75

11.6.3 Financial performance 76

11.6.4 Key developments 76

11.7 Terumo Corporation 77

11.7.1 Company overview 77

11.7.2 Products and services 77

11.7.3 Financial performance 78

11.7.4 Key developments 78

11.8 Penumbra, Inc. 79

11.8.1 Company overview 79

11.8.2 Products and services 79

11.8.3 Financial performance 80

11.8.4 Strategic development 80

11.9 B. Braun Melsungen AG 81

11.9.1 Company overview 81

11.9.2 Products and services 81

11.9.3 Financial performance 83

11.9.4 Key developments 83

11.10 Varian Medical Systems, Inc. 84

11.10.1 Company overview 84

11.10.2 Products and services 84

11.10.3 Financial performance 85

11.10.4 Key developments 85

List of Tables

TABLE 1 Market snapshot: Neurosurgical products market, 2015 and 2022 11

TABLE 2 Drivers for neurological products market: Impact analysis 18

TABLE 3 Restraints for neurological products market: Impact analysis 20

TABLE 4 Global neurosurgical products market size, by region, 2012 - 2014 (US$ Mn) 23

TABLE 5 Global neurosurgical products market size, by region, 2015 - 2022 (US$ Mn) 23

TABLE 6 Global neurosurgical products market size, by condition, 2012 - 2014 (US$ Mn) 24

TABLE 7 Global neurosurgical products market size, by condition, 2015 - 2022 (US$ Mn) 25

TABLE 8 Global neurosurgical products market size, by product type, 2012 - 2014 (US$ Mn) 26

TABLE 9 Global neurosurgical products market size, by product type, 2015 - 2022 (US$ Mn) 27

TABLE 10 Global neurosurgical products market size, by procedure, 2012 - 2014 (US$ Mn) 28

TABLE 11 Global neurosurgical products market size, by procedure, 2015 - 2022 (US$ Mn) 29

TABLE 12 Global hydrocephalus market size, by region, 2012 - 2014 (US$ Mn) 31

TABLE 13 Global hydrocephalus market size, by region, 2015 - 2022 (US$ Mn) 31

TABLE 14 Global aneurysms market size, by region, 2012 - 2014 (US$ Mn) 33

TABLE 15 Global aneurysms market size, by region, 2015 - 2022 (US$ Mn) 33

TABLE 16 Global arteriovenous malformations market size, by region, 2012 - 2014 (US$ Mn) 34

TABLE 17 Global neurosurgical products market size, by region, 2015 - 2022 (US$ Mn) 35

TABLE 18 Global pituitary and intracranial tumors market size, by region, 2012 - 2014 (US$ Mn) 36

TABLE 19 Global pituitary and intracranial tumors market size, by region, 2015 - 2022 (US$ Mn) 37

TABLE 20 Global open neurosurgery market size, by region, 2012 - 2014 (US$ Mn) 38

TABLE 21 Global open neurosurgery market size, by region, 2015 - 2022 (US$ Mn) 39

TABLE 22 Global neurovascular and minimally invasive surgery market size, by region, 2012 - 2014 (US$ Mn) 40

TABLE 23 Global neurovascular and minimally invasive surgery market size, by region, 2015 - 2022 (US$ Mn) 41

TABLE 24 Global shunts market size, by region, 2012 - 2014 (US$ Mn) 43

TABLE 25 Global shunts market size, by region, 2015 - 2022 (US$ Mn) 43

TABLE 26 Global neurosurgical endoscopes market size, by region, 2012 - 2014 (US$ Mn) 44

TABLE 27 Global neurosurgical endoscopes market size, by region, 2015 - 2022 (US$ Mn) 45

TABLE 28 Global stereotactic radio-surgery system market size, by region, 2012 - 2014 (US$ Mn) 47

TABLE 29 Global stereotactic radio-surgery system market size, by region, 2015 - 2022 (US$ Mn) 47

TABLE 30 Global embolization products market size, by region, 2012 - 2014 (US$ Mn) 49

TABLE 31 Global embolization products market size, by region, 2015 - 2022 (US$ Mn) 49

TABLE 32 Global aneurysm and AVM clips market size, by region, 2012 - 2014 (US$ Mn) 50

TABLE 33 Global aneurysm and AVM clips market size, by region, 2015 - 2022 (US$ Mn) 51

TABLE 34 North America neurosurgical products market size, by country, 2012 - 2014 (US$ Mn) 53

TABLE 35 North America neurosurgical products market size, by country, 2015 - 2022 (US$ Mn) 54

TABLE 36 Europe neurosurgical products market size, by country, 2012 - 2014 (US$ Mn) 55

TABLE 37 Europe neurosurgical products market size, by country, 2015 - 2022 (US$ Mn) 56

TABLE 38 Asia Pacific neurosurgical products market size, by country, 2012 - 2014 (US$ Mn) 58

TABLE 39 Asia Pacific neurosurgical products market size, by country, 2015 - 2022 (US$ Mn) 58

TABLE 40 Major product categories of Integra LifeSciences 62

TABLE 41 Product divisions of KARL STORZ 65

TABLE 42 Major product segments of Medtronic plc 68

TABLE 43 Product segments of Johnson and Johnson 71

TABLE 44 Major product segments of Stryker 73

TABLE 45 Major product categories of Elekta AB 75

TABLE 46 Major product segments of Terumo Corporation 77

TABLE 47 Product categories of Penumbra, Inc. 79

TABLE 48 Major product categories of B. Braun 81

TABLE 49 Product segments of Varian Medical Systems, Inc. 84

List of Figures

FIG. 1 Neurosurgical products market: Porter's five forces analysis 12

FIG. 2 Major neurosurgical devices 15

FIG. 3 Aging population in major regions, 2000 - 2050 (% share in total population) 17

FIG. 4 Global neurosurgical products market value share, by region, 2014 22

FIG. 5 Global neurosurgical products market value share, by condition, 2014 24

FIG. 6 Global neurosurgical products market value share, by product type, 2014 25

FIG. 7 Global neurosurgical products market value share, by procedure, 2014 28

FIG. 8 Global hydrocephalus market value share, by region, 2014 30

FIG. 9 Global aneurysms market value share, by region, 2014 32

FIG. 10 Global arteriovenous malformations market value share, by region, 2014 34

FIG. 11 Global pituitary and intracranial tumors market value share, by region, 2014 36

FIG. 12 Global open neurosurgery market value share, by region, 2014 38

FIG. 13 Global neurovascular and minimally invasive surgery market value share, by region, 2014 40

FIG. 14 Global shunts market value share, by region, 2014 42

FIG. 15 Global neurosurgical endoscopes market value share, by region, 2014 44

FIG. 16 Global stereotactic radio-surgery system market value share, by region, 2014 46

FIG. 17 Global embolization products market value share, by region, 2014 48

FIG. 18 A global aneurysm and AVM clips market value share, by region, 2014 50

FIG. 19 North America neurosurgical products market value share, by country, 2014 53

FIG. 20 Europe neurosurgical products market value share, by country, 2014 55

FIG. 21 Asia Pacific neurosurgical products market value share, by country, 2014 57

FIG. 22 Market analysis of major players by product type 60

FIG. 23 Net revenue and net income of Integra LifeSciences Holdings Corporation, 2012 - 2014 (US$ Mn) 63

FIG. 24 Net sales and net earnings of Medtronic, 2012 - 2014 (US$ Mn) 69

FIG. 25 Total sales and net earnings of Johnson and Johnson, 2012 - 2014 (US$ Mn) 72

FIG. 26 Net sales and net earnings of Stryker, 2012 - 2014 (US$ Mn) 74

FIG. 27 Net sales and profit of Elekta AB, 2011 - 2013 (US$ Mn) 76

FIG. 28 Net sales and net income of Terum Corporation, 2012 - 2014 (US$ Mn) 78

FIG. 29 Sales and net income of B. Braun Melsungen, 2012 - 2014 (US$ Mn) 83

FIG. 30 Varian Medical Systems, Inc.'s revenue and net earnings, 2012 - 2014 (US$ Mn) 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.